BENDAMUSTINE REDDY PHARMA 180 mg/4 ml, solution concentrated for dilution for solution for infusion bottle, 4 ml
Active ingredients: Bendamustine hydrochloride, Bendamustine hydrochloride monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 4 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BENDAMUSTINE REDDY PHARMA 180 mg/4 ml, solution concentrée à diluer pour solution pour perfusion
- Pharmaceutical form
- solution concentré(e) à diluer pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre brun de 4 ml
- Marketing authorisation holder
- REDDY PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Feb 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67424650CIP75504228CIP133400955042280Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE BENDAMUSTINE MONOHYDRATÉsolution | — | SA |
| CHLORHYDRATE DE BENDAMUSTINEsolution | 180 mg · 4 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.